Riccardo Polosa on Ecig Evidence

Posted 25th July 2016 by Dave Cross
Riccardo Polosa, from the University of Catania, made a presentation on electronic cigarette evidence at the Global Forum for Nicotine. The full title of his presentation was “Ecigarettes health potential: current evidence and future areas of exploration”.

He began by introducing the work he did with Doctor Konstantinos Farsalinos where they looked at the effect of vaping on the blood pressure of smokers making the switch. “Blood pressure is a common problem for many people,” he said while point out that this could be a way to bring “allies” into the vape debate. Their work, as we covered here on Planet Of The Vapes, demonstrated a reversal of blood pressure problems when people used an electronic cigarette to quit smoking.

Further investigation demonstrated that vaping was strongly linked to smoking cessation, not something that the team highlighted at the time. This further avenue of enquiry also highlighted significant changes in systolic and diastolic blood pressure reading for the better. “This is something that is not good news to the drug industry,” he took pleasure in adding.

Not good news for the drug industry because the data demonstrated that ecigs were more effective at controlling blood pressure in patients with a historical medical problem than their previous medication.

Evidence of improvement in hypertension was recorded in 1149 individuals, representing half of the subjects. Meanwhile 40% demonstrated no change through adverse effects. All told, Polosa stated that vaping lowers blood pressure, works at improving blood pressure control in hypertension patients, displayed positive results even for those dual-fuelling and offers a “helpful alternative to cigarettes”.

He went on to speak about the improvements vaping lends to the respiratory system. Coughing and wheezing were reported also as being reduced in those switching to ecigs. Turning to asthma, Polosa talked about the improvement in “quality of life” for those suffering from the affliction, countering the lies made about vaping increasing the chances of attacks. The COPD data tells the same tale of improvements in life quality after switching to electronic cigarettes.

Then Riccardo moved on to the subject of where nicotine can help in the treatment of medical conditions. As a much-maligned drug, it offers huge potential as a therapeutic tool in the management of Parkinson’s, ulcerative colitis, depression, schizophrenia, ADHD and mild cognitive impairment.

 Dave Cross
Article by Dave Cross
Freelance writer, physicist, karateka, dog walker